Recurrent Kikuchi’s Disease Treated by Hydroxychloroquine

다국어 초록 (Multilingual Abstract)

Kikuchi-Fujimoto disease (KFD) is a benign, self-limiting disease, with a specific histopathology. It can be diagnosed clinically, and specific symptoms include fever and cervical lymphadenopathy. The histological finding of KFD in cervical lymph nodes includes necrotizing lymphadenitis. KFD needs conservative treatments. If KFD persists for a long period, steroids or nonsteroidal antiinflammatory drugs can be used to control symptoms. Previous studies have reported the treatment of KFD with hydroxychloroquine (HC) in patients unresponsive to steroids. Herein, we report a case of a 25-year-old female patient diagnosed with KFD unresponsive to steroids, and was successfully treated with HC.

참고문헌 (Reference)

1 Facchetti F, "The plasmacytoid monocyte/interferon producing cells" 443 : 703-717, 2003

2 Lin DY, "Severe Kikuchi's disease responsive to immune modulation" 51 : e18-e21, 2010

3 Yoo IH, "Recurrent lymphadenopathy in children with Kikuchi-Fujimoto disease" 173 : 1193-1199, 2014

4 Olsen NJ, "Multifaceted effects of hydroxychloroquine in human disease" 43 : 264-272, 2013

5 Kikuchi M, "Lymphadenitis showing focal reticulum cells hyperplasia with nuclear debris and phagocytosis: A clinicopathological study" 35 : 379-380, 1972

6 Ram R, "Kikuchi–Fujimoto disease associated with systemic lupus erythematosus" 4 : 238-240, 2011

7 Rezai K, "Kikuchi-Fujimoto disease: hydroxychloroquine as a treatment" 39 : e124-e126, 2004

8 Hutchinson CB, "Kikuchi-Fujimoto disease" 134 : 289-293, 2010

9 Kucukardali Y, "Kikuchi-Fujimoto Disease: analysis of 244 cases" 26 : 50-54, 2007

10 Ohshima K, "Interferon-gamma, interleukin-18, monokine induced by interferon-gamma and interferon-gamma-inducible protein-10 in histiocytic necrotizing lymphadenitis" 43 : 1115-1120, 2002

11 van Loosdregt J, "Hydroxychloroquine preferentially induces apoptosis of CD45RO+ effector T cells by inhibiting autophagy:a possible mechanism for therapeutic modulation of T cells" 131 : 1443.e.1-1446.e.1, 2013

12 Sacre K, "Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus" 14 : R155-, 2012

13 Goldman FD, "Hydroxychloroquine inhibits calcium signals in T cells: a new mechanism to explain its immunomodulatory properties" 95 : 3460-3466, 2000

14 Bosch X, "Enigmatic Kikuchi-Fujimoto disease: a comprehensive review" 122 : 141-152, 2004

15 Barrera P, "Effects of antirheumatic agents on cytokines" 25 : 234-253, 1996

16 Uslu E, "Disseminated intravascular coagulopathy caused by Kikuchi-Fujimoto disease resulting in death: first case report in Turkey" 7 : 19-22, 2014

17 Nayak HK, "Diagnostic dilemma: Kikuchi's disease or tuberculosis?" 008026-, 2013

18 Song JY, "Clinical outcome and predictive factors of recurrence among patients with Kikuchi's disease" 13 : 322-326, 2009

19 Fujimoto Y, "Cervical subacute necrotizing lymphadenitis" 30 : 920-927, 1972

20 Goldblatt F, "Association of Kikuchi-Fujimoto's disease with SLE" 47 : 553-554, 2008